March 2022

breaking news

B-cell immunity against SARS-CoV-2 in unexposed individuals

In a recent paper, Ercanoglu, et al., sought out to provide a detailed analysis of the B cell immunity to SARS-CoV-2 in unexposed individuals, investigating pre-pandemic blood samples from 150…

ChelekaMarch 29, 2022

breaking news

Enhanced production of effective and personalised vaccines for cancer

In a recent paper by Feola, et al., researchers have developed a pipeline for evaluating, prioritising and identifying potential tumour antigens for the production of vaccines against cancers. The pipeline currently being…

StefanMarch 29, 2022

breaking news

COVID-19: antigen-specific T cell response and immuno-metabolomic signatures

In a new study by Binayke, et al., the researchers investigated the innate and adaptive immune responses during both the late and early stage of SARS-CoV-2 infection. They also wanted…

StefanMarch 23, 2022

breaking news

Biomarkers to identify Mycobacterium tuberculosis-infection: finding the needle in a haystack

In a recent paper, the authors sought to identify a biomarker profile that can be used to differentiate borderline QFT results, due to TB-infection, from those that are a result…

ChelekaMarch 19, 2022

breaking news

T cells and skin disease

Roediger, et al., suggested that the role of T cells, particularly due to their implication in the TH2 phenotype, in Inflammatory skin disease (ISD) could be a therapeutic avenue which…

ChelekaMarch 16, 2022

breaking news

B-cell immunity following SARS-COV-2 mRNA vaccination – 6 months on…

In a recent paper by Markewitz, et al., the researchers aimed to investigate and determine the levels of anti-SARS-CoV-2 antibodies in individuals who have been vaccinated with a mRNA COVID-19…

ChelekaMarch 15, 2022

breaking news

A potential mRNA vaccine for SARS-CoV-2 Omicron variant

In a recent study, Wu, et al., aimed to develop a messenger ribonucleic acid (mRNA) vaccine using the SARS-CoV-2 Omicron variant sequence as a target. The aim was to develop…

ChelekaMarch 11, 2022

breaking news

More than a gut feeling: The implication of gut microbiota in the pathology of Alzheimer’s Disease

A recent study by Verhaar et al, investigated associations among patients with Alzheimer's' disease pathology and their gut microbiota. This study demonstrates that the gut microbiome composition is linked to…

ChelekaMarch 10, 2022

breaking news

MAIT cells – a new target for future immunotherapies and vaccines

In a recent study, researchers have demonstrated that mucosal-associated invariant T (MAIT) cells, a form of immune cells, play several complex roles during diseased and healthy conditions. These MAIT cells…

ChelekaMarch 7, 2022

breaking news

Immune memory in the intestine: new insights into “innate memory”

In a recent paper, Serafinain, et al., have made us of an intestinal infection model to discover that group 3 innate lymphoid cells (cells of the innate immune system) may…

ChelekaMarch 3, 2022

B-cell immunity against SARS-CoV-2 in unexposed individuals

Enhanced production of effective and personalised vaccines for cancer

COVID-19: antigen-specific T cell response and immuno-metabolomic signatures

Biomarkers to identify Mycobacterium tuberculosis-infection: finding the needle in a haystack

T cells and skin disease

B-cell immunity following SARS-COV-2 mRNA vaccination – 6 months on…

A potential mRNA vaccine for SARS-CoV-2 Omicron variant

More than a gut feeling: The implication of gut microbiota in the pathology of Alzheimer’s Disease

MAIT cells – a new target for future immunotherapies and vaccines

Immune memory in the intestine: new insights into “innate memory”

Advancing Global Online Immunology Education for 20 years

Join our Newsletter

Advancing Global Immunology Education